Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: A matched-pair analysis

Technology in Cancer Research and Treatment

Volumn 12, Issue 2, 2013, Pages 123-130

  Al Mamgani, Abrahim ^a   Van Rooij, Peter ^a   Tans, Lisa ^a   Teguh, David N ^a   Levendag, Peter C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

3DCRT; IMRT; Matched pair analysis; Oropharyngeal cancer; Toxicity

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER CONTROL; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; DYSPHAGIA; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MUCOSAL DISEASE; MULTIPLE CYCLE TREATMENT; OROPHARYNX CANCER; OVERALL SURVIVAL; PAIN; SKIN TOXICITY; TREATMENT OUTCOME; TRISMUS; TUMOR VOLUME; XEROSTOMIA;

EID: 84873454539     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500305     Document Type: Article

References (15)

1. Pignon, J. P., le Maitre, A., Maillard, E., Bourhis J. MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients. Radiother Oncol 92, 4-14 (2009). DOI: 10.1016/j.radonc.2009.04.014
2. Setton, J., Caria, N., Romanyshy, J., Koutcher, L., Wolden, S. L., Zelefsky, M. J., Rowan, N., Sherman, E. J., Fury, M. G., Pfster, D. G., Wong, R. J., Shah, J. P., Kraus, D. H., Shi, W., Zhang, Z., Schupak, K. D., Gelblum, D. Y., Rao, S. D., Lee, N. Y. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 82, 291-298 (2012). DOI: 10.1016/ j.ijrobp.2010.10.041
3. Dirix, P., Nuyts, S. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 78, 1373-1380 (2010). DOI: 10.1016/ j.ijrobp.2009.10.018
4. Chao, K. S., Deasy, J. O., Markman, J., Haynie, J., Perez, C. A., Purdy, J. A., Low, D. A. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49, 907-916 (2001). DOI: 10.1016/S0360-3016(00)01441-3
5. Mendenhall, W. M., Amdur, R., Morris, C. G., Kirwan, J. M., Li, J. G. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope 11, 2218-2222 (2010). DOI: 10.1002/lary.21144
6. de Graaf, M. A., Jager, K. J., Zoccali, C., Dekker, F. W. Matching, an appealing method to avoid confounding. Nephron Clin Pract 118, c315-318 (2011). DOI: 10.1159/000323136
7. D'Hondt, E., Eisbruch, A., Ship, J. A. The infuence of pre-radiation salivary fow rates and radiation dose on parotid salivary gland dysfunction in patients receiving radiotherapy for head and neck cancers. Spec Care Dentist 18, 102-108 (1998). DOI: 10.1111/ j.1754-4505.1998.tb00913.x
8. Nutting, C. M., Morden, J. P., Harrington, K. J., Urbano, T. G., Bhide, S. A., Clark, C., Miles, E. A., Miah, A. B., Newbold, K., Tanay, M., Adab, F., Jefferies, S. J., Scrase, C., Yap, B. K., A'Hern, R. P., Sydenham, M. A., Emson, M., Hall, E. PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12, 127-136 (2011). DOI: 10.1016/S1470-2045(10)70290-4
9. Little, M., Schipper, M., Feng, F. Y., Vineberg, K., Cornwall, C., Murdoch-Kinch, C. A., Eisbruch, A. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: Beyond sparing the parotid glands. Int J Radiat Oncol Biol Phys 83, 1007-1014 (2012). DOI: 10.1016/j.ijrobp.2011.09.004
10. Levendag, P. C., Teguh, D. N., Voet, P., van der Est, H., Noever, I., de Kruijf, W. J., Kolkman-Deurloo, I. K. Dysphagia disorders in patients with cancer of the oropharynx are signifcantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiother Oncol 85, 64-73 (2007). DOI: 10.1016/j.radonc.2007.07.009
11. Logemann, J. A., Smith, C. H., Pauloski, B. R., Rademaker, A. W., Lazarus, C. L., Colangelo, L. A., Mittal, B., MacCracken, E., Gaziano, J., Stachowiak, L., Newman, L. A. Effects of xerostomia on perception and performance of swallow function. Head Neck 23, 317-321 (2001). DOI: 10.1002/hed.1037
12. Teguh, D. N., Levendag, P. C., Noever, I., van Rooij, P. P., van der Est, H., Sipkema, D., Sewnaik, A., Baatenburg de Jong, R. J., de la Bije, D., Schmitz, P. I. Treatment techniques and site considerations regarding dysphagia-related quality of life in cancer of the orophar-ynx and nasopharynx. Int J Radiat Oncol Biol Phys 72, 1119-1127 (2008). DOI: 10.1016/j.ijrobp.2008.02.061
13. Hodge, C., Bentzen, S. M., Wong, G., Palazzi-Churas, K. L., Wiederholt, P. A., Gondi, V., Richards, G. M., Hartig, G. K., Harari, P. M. Are we infuencing outcome in oropharynx cancer with intensity-modulated radiotherapy? An inter-era comparison. Int J Radiat Oncol Biol Phys 69, 1032-1041 (2007). DOI: 10.1016/ j.ijrobp.2007.05.017
14. Rusthoven, K. E., Raben, D., Ballonoff, A., Kane, M., Song, J. I., Chen, C. Effect of radiation techniques in treatment of orophar-ynx cancer. Laryngoscope 118, 635-639 (2008). DOI: 10.1097/ MLG.0b013e31815fdf0e
15. Ang, K. K., Harris, J., Wheele, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., Kim, H., Axelrod, R., Silverman, C. C., Redmond, K. P., Gillison, M. L. Human papilloma virus and survival of patients with oropharyngeal cancer. N Engl J Med 363, 24-35 (2010). DOI: 10.1056/NEJMoa0912217